Asset Details
Do you wish to reserve the book?
Inpatient Glycemic Variability and Long-Term Mortality in Hospitalized Patients with Type 2 Diabetes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Inpatient Glycemic Variability and Long-Term Mortality in Hospitalized Patients with Type 2 Diabetes
Do you wish to request the book?
Inpatient Glycemic Variability and Long-Term Mortality in Hospitalized Patients with Type 2 Diabetes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Inpatient Glycemic Variability and Long-Term Mortality in Hospitalized Patients with Type 2 Diabetes
2017
Overview
To determine the association between inpatient glycemic variability and long-term mortality in patients with type 2 diabetes mellitus.
Capillary blood glucose (CBG) of inpatients from 8 hospitals was analysed. 28,353 admissions identified were matched for age, duration of diabetes and admission and median and interquartile range of CBG. 6year mortality was investigated for (i) those with CBG IQR in the top half of all IQR measurements (matched for all except IQR), vs those in the lower half and (ii) those with the lowest quartile median glucose (matched for all except median).
1.Glycemic variability3165 matched pairs were analysed. Mortality was greater in those with IQR in upper 50% (≥50.9mg/dl) over follow-up from day 90 post-discharge to a maximum of 6years (p<0.01, HR 1.17).2.Median glucose2.3755 matched pairs were analysed. Mortality was lower in those with a median glucose in upper 50% (≥148.5mg/dl) over follow-up from day 90 post-discharge to a maximum of 6years (p <0.01, HR 0.87).
Higher inpatient glycemic variability is associated with increased mortality on long-term follow up. When matched by IQR, we have demonstrated higher median CBG is associated with lower long-term mortality. CBG variability may increase cardiovascular morbidity by increasing exposure to hypoglycaemia or to variability per se. In hospitalized patients with diabetes, glycemic variability should be minimised and when greater CBG variability is unavoidable, a less stringent CBG target considered.
Publisher
Elsevier Inc,Elsevier Limited
Subject
/ Aged
/ Cardiovascular Diseases - complications
/ Cardiovascular Diseases - mortality
/ Cardiovascular Diseases - prevention & control
/ Combined Modality Therapy - adverse effects
/ Datasets
/ Diabetes
/ Diabetes Complications - mortality
/ Diabetes Complications - prevention & control
/ Diabetes Mellitus, Type 2 - blood
/ Diabetes Mellitus, Type 2 - complications
/ Diabetes Mellitus, Type 2 - mortality
/ Diabetes Mellitus, Type 2 - therapy
/ Diabetic Angiopathies - mortality
/ Diabetic Angiopathies - prevention & control
/ Diabetic Cardiomyopathies - mortality
/ Diabetic Cardiomyopathies - prevention & control
/ Female
/ Glucose
/ Humans
/ Hyperglycemia - prevention & control
/ Hypoglycemia - prevention & control
/ Male
/ Patients
